Todd Harris
2021 - Tyra Biosciences
In 2021, Todd Harris earned a total compensation of $6.4M as Chief Executive Officer at Tyra Biosciences, a 415% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $168,916 |
|---|---|
| Option Awards | $5,764,839 |
| Salary | $442,822 |
| Other | $986 |
| Total | $6,377,563 |
Harris received $5.8M in option awards, accounting for 90% of the total pay in 2021.
Harris also received $168.9K in non-equity incentive plan, $442.8K in salary and $986 in other compensation.
Rankings
In 2021, Todd Harris' compensation ranked 1,995th out of 12,415 executives tracked by ExecPay. In other words, Harris earned more than 83.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,995 out of 12,415 | 84th |
Division Manufacturing | 758 out of 5,501 | 86th |
Major group Chemicals And Allied Products | 294 out of 2,371 | 88th |
Industry group Drugs | 253 out of 2,092 | 88th |
Industry Pharmaceutical Preparations | 163 out of 1,542 | 89th |
Source: SEC filing on April 28, 2022.
Harris' colleagues
We found three more compensation records of executives who worked with Todd Harris at Tyra Biosciences in 2021.